GlassScriptPhysician profile
Ryan T Schulte
NPI 1669598942
$3,376.48
in general payments reported to CMS, 2019-2025
30 companies · $323 in 2025
The $323 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $698 · 2020: $334 · 2021: $604 · 2022: $493 · 2023: $313 · 2024: $612 · 2025: $323.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,248.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,247.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $414.05 | 2019-2022 | |
| Medtronic, INC. | $383.04 | 2021-2024 | Interstim |
| Dornier Medtech America, INC | $291.49 | 2019-2024 | Dornier Medtech |
| Neotract INC. | $288.22 | 2019-2020 | |
| Olympus America INC. | $190.62 | 2019-2024 | Itind System, Uretero-Reno Videoscope, Hd Camera Head |
| Janssen Biotech, INC. | $182.85 | 2020-2022 | |
| Teleflex LLC | $174.35 | 2022 | |
| Intuitive Surgical, INC. | $154.13 | 2019 | |
| Abbvie INC. | $134.66 | 2019-2024 | Botox |
| Merck Sharp & Dohme LLC | $128.69 | 2022-2025 | Keytruda, Bridion |
| Procept Biorobotics Corporation | $107.62 | 2022 | |
| Karl Storz Endoscopy-America | $93.30 | 2019-2024 | |
| Medtronic USA, INC. | $91.84 | 2019 | |
| Axonics, INC. | $88.97 | 2022-2024 | Bulkamid, Axonics |
| Pfizer INC. | $85.36 | 2021-2025 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $84.29 | 2024-2025 | |
| Myriad Genetic Laboratories, INC. | $76.96 | 2020-2023 | Prolaris, Myrisk |
| Coloplast Corp | $69.54 | 2020-2022 | |
| Verity Pharmaceuticals INC. | $55.34 | 2023 | Trelstar |
| Travere Therapeutics, INC. | $45.62 | 2020-2021 | |
| Endo Pharmaceuticals INC. | $37.33 | 2020-2023 | Xiaflex, Aveed |
| Cook Medical LLC | $33.91 | 2024-2025 | Resonance, S~Curve |
| Conmed Corporation | $32.63 | 2024 | Airseal |
| Profound Medical Corp. | $26.81 | 2025 | Tulsa-Pro |
| Calyxo, INC. | $25.44 | 2025 | Cvac Aspiration System |
| Tolmar Pharmaceuticals, INC. | $19.49 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $16.81 | 2025 | |
| Myovant Sciences INC. | $16.16 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $14.71 | 2023 | Opdivo |
| Valencia Technologies Corporation | $12.25 | 2025 | Ecoin Device Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Schulte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.